GLIMEPIRIDE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 17 adverse event reports in the FDA FAERS database where GLIMEPIRIDE was used for Psoriasis.
Most Reported Side Effects for GLIMEPIRIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hypoglycaemia | 1,403 | 25.2% | 71 | 967 |
| Blood glucose increased | 446 | 8.0% | 6 | 102 |
| Acute kidney injury | 339 | 6.1% | 46 | 220 |
| Drug ineffective | 339 | 6.1% | 1 | 60 |
| Diarrhoea | 257 | 4.6% | 44 | 115 |
| Blood glucose decreased | 232 | 4.2% | 8 | 68 |
| Lactic acidosis | 219 | 3.9% | 40 | 130 |
| Glycosylated haemoglobin increased | 214 | 3.8% | 1 | 55 |
| Diabetes mellitus inadequate control | 213 | 3.8% | 2 | 46 |
| Hypoglycaemic coma | 187 | 3.4% | 15 | 123 |
| Toxicity to various agents | 185 | 3.3% | 71 | 139 |
| Nausea | 180 | 3.2% | 38 | 99 |
| Vomiting | 178 | 3.2% | 5 | 128 |
| Fall | 150 | 2.7% | 6 | 123 |
| Completed suicide | 146 | 2.6% | 146 | 49 |
Other Indications for GLIMEPIRIDE
Type 2 diabetes mellitus (1,681)
Diabetes mellitus (1,298)
Product used for unknown indication (1,267)
Hyperglycaemia (43)
Blood glucose increased (37)
Suicide attempt (29)
Blood glucose abnormal (19)
Type 1 diabetes mellitus (14)
Blood glucose decreased (12)
Accidental exposure to product (10)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)